A detailed history of Vanguard Group Inc transactions in Biogen Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 16,600,163 shares of BIIB stock, worth $2.88 Billion. This represents 0.08% of its overall portfolio holdings.

Number of Shares
16,600,163
Previous 16,570,398 0.18%
Holding current value
$2.88 Billion
Previous $3.57 Billion 7.7%
% of portfolio
0.08%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$190.52 - $236.72 $5.67 Million - $7.05 Million
29,765 Added 0.18%
16,600,163 $3.85 Billion
Q1 2024

May 10, 2024

BUY
$212.02 - $267.71 $459 Million - $579 Million
2,163,068 Added 15.01%
16,570,398 $3.57 Billion
Q4 2023

Feb 14, 2024

BUY
$222.59 - $267.94 $494 Million - $594 Million
2,218,744 Added 18.2%
14,407,330 $3.73 Billion
Q3 2023

Nov 14, 2023

SELL
$253.3 - $285.89 $1.99 Million - $2.24 Million
-7,850 Reduced 0.06%
12,188,586 $3.13 Billion
Q2 2023

Aug 14, 2023

BUY
$275.25 - $318.06 $10.7 Million - $12.3 Million
38,774 Added 0.32%
12,196,436 $3.47 Billion
Q1 2023

Jul 14, 2023

BUY
$256.56 - $292.34 $107,242 - $122,198
418 Added 0.0%
12,157,662 $3.38 Billion
Q1 2023

May 15, 2023

BUY
$256.56 - $292.34 $46.3 Million - $52.8 Million
180,621 Added 1.51%
12,157,244 $3.38 Billion
Q4 2022

Feb 10, 2023

BUY
$252.44 - $306.72 $15.6 Million - $18.9 Million
61,650 Added 0.52%
11,976,623 $3.32 Billion
Q3 2022

Nov 14, 2022

BUY
$194.69 - $268.46 $10.7 Million - $14.8 Million
54,951 Added 0.46%
11,914,973 $3.18 Billion
Q2 2022

Aug 12, 2022

BUY
$187.54 - $223.02 $26.2 Million - $31.1 Million
139,438 Added 1.19%
11,860,022 $2.42 Billion
Q1 2022

May 13, 2022

BUY
$193.77 - $244.14 $35.5 Million - $44.7 Million
183,285 Added 1.59%
11,720,584 $2.47 Billion
Q4 2021

Feb 14, 2022

SELL
$223.92 - $287.77 $34.6 Million - $44.5 Million
-154,577 Reduced 1.32%
11,537,299 $2.77 Billion
Q3 2021

Nov 12, 2021

SELL
$282.99 - $369.05 $17.4 Million - $22.7 Million
-61,457 Reduced 0.52%
11,691,876 $3.31 Billion
Q2 2021

Aug 13, 2021

BUY
$259.0 - $414.71 $3.04 Billion - $4.87 Billion
11,753,333 New
11,753,333 $4.07 Billion

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Vanguard Group Inc Portfolio

Follow Vanguard Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.